ENSYSCE BIOSCIENCES, INC. Income Taxes Paid
ENSYSCE BIOSCIENCES, INC. (ENSC) reported Income Taxes Paid of $125.70 thousand for the 12-month period ending 2020-12-31, per its 10-K/A filed 2021-06-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2021-06-08
- ENSYSCE BIOSCIENCES, INC. income taxes paid for the quarter ending 2019-12-31 was $173.00K, a 50.57% decline year-over-year.
- ENSYSCE BIOSCIENCES, INC. income taxes paid for the quarter ending 2019-09-30 was $104.00K, a 19.87% decline year-over-year.
- ENSYSCE BIOSCIENCES, INC. income taxes paid for the quarter ending 2018-12-31 was $350.00K.
- ENSYSCE BIOSCIENCES, INC. income taxes paid for the quarter ending 2018-09-30 was $129.79K.
- ENSYSCE BIOSCIENCES, INC. income taxes paid for fiscal 2020 was $125.70K, a 76.06% decline from fiscal 2019.
- ENSYSCE BIOSCIENCES, INC. income taxes paid for fiscal 2019 was $525.00K, a 27.72% decline from fiscal 2018.
- ENSYSCE BIOSCIENCES, INC. income taxes paid for fiscal 2018 was $726.32K.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2020-12-31 | $125.70K 10-K/A · filed 2021-06-08 | |||
| 2019-12-31 | $173.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-06-08 | $277.00K derived: sum of 2 quarters · filed 2021-06-08 | $525.00K 10-K/A · filed 2021-06-08 | |
| 2019-09-30 | $104.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $352.00K 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | $248.00K 10-Q · filed 2020-08-07 | |||
| 2018-12-31 | $350.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $479.79K derived: sum of 2 quarters · filed 2020-03-10 | $726.32K 10-K · filed 2020-03-10 | |
| 2018-09-30 | $129.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $376.32K 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | $246.54K 10-Q · filed 2019-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |